Comparable outcomes for patients with pT1a and pT1b differentiated thyroid cancer: Is there a need for change in the AJCC classification system? Journal Article


Authors: Wang, L. Y.; Nixon, I. J.; Palmer, F. L.; Thomas, D.; Tuttle, R. M.; Shaha, A. R.; Patel, S. G.; Shah, J. P.; Ganly, I.
Article Title: Comparable outcomes for patients with pT1a and pT1b differentiated thyroid cancer: Is there a need for change in the AJCC classification system?
Abstract: Introduction. The current American Joint Committee on Cancer TNM classification for differentiated thyroid cancer (DTC) separates T1 status into T1a and T1b based on a 1-cm cutoff for maximal tumor dimension. In 2009, the American Thyroid Association recommended total thyroidectomy for tumors >1 cm in contrast to the possibility of lobectomy for tumors ≤1 cm. Our aim was to investigate the prognostic significance of a 1-cm tumor cutoff. Methods. From an institutional database of 3,664 patients with DTC, 1,522 patients with T1 tumors without neck disease or distant metastases were identified. Patient, tumor, and treatment characteristics were compared. Disease-specific survival (DSS) and recurrence-free survival (RFS) outcomes were analyzed. Results. Total thyroidectomy rates were similar between patients with T1a and T1b tumors (P = .307). With a median follow-up of 46 months (range, 1-320), there were no disease-specific deaths in the T1a or T1b groups. In total, 18 patients (1.2%) experienced a recurrence. Five-year RFS was comparable for patients with T1a and T1b tumors (98.6 vs 98.6%; P = .224). Conclusion. T1a and T1b tumors have similar prognosis both in terms of DSS and RFS. It seems that a distinction between tumors of <1 and >1 cm is of no prognostic benefit.
Keywords: adolescent; adult; cancer survival; child; controlled study; aged; cancer surgery; major clinical study; cancer recurrence; multimodality cancer therapy; cancer staging; outcome assessment; recurrence risk; follow up; radiation exposure; radioactive iodine; cancer size; medical society; thyroidectomy; thyroid tumor; disease specific survival; thyrotropin; recurrence free survival; differentiated thyroid cancer; subtotal thyroidectomy; hormone inhibition; cancer prognosis; human; male; female; priority journal; article
Journal Title: Surgery
Volume: 156
Issue: 6
ISSN: 0039-6060
Publisher: Elsevier Inc.  
Date Published: 2014-12-01
Start Page: 1484
End Page: 1489
Language: English
DOI: 10.1016/j.surg.2014.08.037
PROVIDER: scopus
PUBMED: 25456937
DOI/URL:
Notes: Export Date: 2 March 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ashok R Shaha
    697 Shaha
  2. Snehal G Patel
    412 Patel
  3. Robert M Tuttle
    481 Tuttle
  4. Iain James Nixon
    60 Nixon
  5. Ian Ganly
    430 Ganly
  6. Jatin P Shah
    721 Shah
  7. Frank Palmer
    82 Palmer
  8. Dorothy Thomas
    9 Thomas
  9. Laura Wang
    42 Wang